+

WO2002031114A3 - Expression genique module dans l'ileite - Google Patents

Expression genique module dans l'ileite Download PDF

Info

Publication number
WO2002031114A3
WO2002031114A3 PCT/US2001/032091 US0132091W WO0231114A3 WO 2002031114 A3 WO2002031114 A3 WO 2002031114A3 US 0132091 W US0132091 W US 0132091W WO 0231114 A3 WO0231114 A3 WO 0231114A3
Authority
WO
WIPO (PCT)
Prior art keywords
ileitis
gene expression
expression modulated
modulated
polynucleotides
Prior art date
Application number
PCT/US2001/032091
Other languages
English (en)
Other versions
WO2002031114A2 (fr
Inventor
Joanne L Viney
John E Sims
Robert F Dubose
Peter R Baum
Karl W Hasel
Brian S Hilbush
Original Assignee
Digital Gene Tech Inc
Joanne L Viney
John E Sims
Robert F Dubose
Peter R Baum
Karl W Hasel
Brian S Hilbush
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Digital Gene Tech Inc, Joanne L Viney, John E Sims, Robert F Dubose, Peter R Baum, Karl W Hasel, Brian S Hilbush filed Critical Digital Gene Tech Inc
Priority to AU2002213207A priority Critical patent/AU2002213207A1/en
Publication of WO2002031114A2 publication Critical patent/WO2002031114A2/fr
Publication of WO2002031114A3 publication Critical patent/WO2002031114A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des polynucléotides, des polypeptides, des kits et des méthodes en relation avec des caractéristiques géniques de l'iléite.
PCT/US2001/032091 2000-10-11 2001-10-11 Expression genique module dans l'ileite WO2002031114A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002213207A AU2002213207A1 (en) 2000-10-11 2001-10-11 Gene expression modulated in ileitis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23948300P 2000-10-11 2000-10-11
US60/239,483 2000-10-11

Publications (2)

Publication Number Publication Date
WO2002031114A2 WO2002031114A2 (fr) 2002-04-18
WO2002031114A3 true WO2002031114A3 (fr) 2002-07-18

Family

ID=22902347

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/032091 WO2002031114A2 (fr) 2000-10-11 2001-10-11 Expression genique module dans l'ileite

Country Status (2)

Country Link
AU (1) AU2002213207A1 (fr)
WO (1) WO2002031114A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103459608B (zh) * 2011-04-01 2018-05-01 中外制药株式会社 重组多肽的制造方法
EP4543478A2 (fr) * 2022-06-24 2025-04-30 The University of Chicago Procédés et compositions pour le traitement de conditions inflammatoires et auto-immunes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000077166A2 (fr) * 1999-06-10 2000-12-21 Digital Gene Technologies, Inc. Expression genique modulee dans des inflammations gastro-intestinales
US6228585B1 (en) * 1998-09-04 2001-05-08 Washington University Gene markers for chronic mucosal injury
US6365352B1 (en) * 1997-08-22 2002-04-02 Yale University Process to study changes in gene expression in granulocytic cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365352B1 (en) * 1997-08-22 2002-04-02 Yale University Process to study changes in gene expression in granulocytic cells
US6228585B1 (en) * 1998-09-04 2001-05-08 Washington University Gene markers for chronic mucosal injury
WO2000077166A2 (fr) * 1999-06-10 2000-12-21 Digital Gene Technologies, Inc. Expression genique modulee dans des inflammations gastro-intestinales

Also Published As

Publication number Publication date
AU2002213207A1 (en) 2002-04-22
WO2002031114A2 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2086199A (en) Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof
MXPA02004878A (es) Genes relacionados con la bioquimica de la planta.
AU2001254885A1 (en) Modified ES cells and ES cell-specific gene
AU2003304203A1 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
WO2004022586A3 (fr) Gene de biosynthese de tubulysine
AU6758798A (en) Dna glycosylase inhibitors, and uses related thereto
WO2004024940A3 (fr) Modulation d'un gene mediee par arn
AU9425798A (en) Method and kit for amplification, sequencing and typing of classical hla class igenes
AU2001264935A1 (en) Method for introducing and expressing genes in animal cells, and bacterial blebsfor use in same
AU2002228805A1 (en) Antisense modulation of damage-specific dna binding protein 2, p48 expression
WO2002031114A3 (fr) Expression genique module dans l'ileite
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
AU2003256100A1 (en) Coloring method of natural leather, and colored natural leather using the same
AU2001256232A1 (en) Genes isolated from dendritic cells, gene products and methods employing the same
AU2002362800A1 (en) Modulation of the expression of genes dependent on stat-1
WO2000077166A3 (fr) Expression genique modulee dans des inflammations gastro-intestinales
WO2002006463A3 (fr) Regulation d'expression genique a l'aide de commutateurs polypeptidiques monomeres a chaine unique dependant d'un ligand
AU2001296365A1 (en) Methods for cloning, sequencing and expressing genes from complex microbial populations
WO2002042420A3 (fr) Modulation de l'expression de genes lors de l'hyperplasie de l'intima de l'artere carotide
WO2001029179A3 (fr) Regulation de l'expression genetique par des neuromodulateurs
AU8229901A (en) Genes and proteins, and their uses
WO2000073324A3 (fr) Modulation d'expression genique dans une inflammation gastro-intestinale
AU5545896A (en) H. Influenzae HxuB and HxuC genes, proteins and methods of use
WO2002081726A3 (fr) Modulation de l'expression genetique dans des modeles genetiques murins de l'atherosclerose
AU2002217911A1 (en) Basal cell carcinoma cultures, methods related thereto and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载